North America Veterinary Antimicrobial Susceptibility Testing Market Size, Share & Forecast Report, 2034
The revenue of the North America veterinary AST market demonstrated a consistent upward trend from 2020 to 2035. In 2025, the market size is anticipated to reach 460 Million USD, reflecting robust growth propelled by expanding adoption of AST solutions across both clinical and field settings. Factors such as growing regulatory focus on antimicrobial stewardship, technological innovation in rapid and automated diagnostics, and increased incidence of zoonotic diseases are major contributors to this upward trajectory. The market is expected to continue its growth momentum through 2035.
Livestock applications are projected to account for the largest share of the North American veterinary AST market in 2025, driven by high testing requirements in the food animal sector. Companion animals are the second-largest segment, fueled by rising pet ownership and intensifying focus on pet health. Aquaculture and diagnostic laboratory usage are steadily growing segments as well, benefiting from increased awareness and expanding regulatory oversight. This segmentation underscores the high utility and necessity of susceptibility testing across various animal health markets.
Request Free Sample- https://bussinessinsights.com/request/healthcare/north-america-veterinary-antimicrobial-susceptibility-testing-market
Frequently Asked Questions
Who are the key players in North America Veterinary Antimicrobial Susceptibility Testing Market industry?
The top 5 key players include bioMérieux SA, Thermo Fisher Scientific, Becton, Dickinson and Company (BD), Neogen Corporation, and Bruker Corporation. These companies are leading the market due to their innovative product portfolios, research advancements, and extensive distribution networks across North America.
What is the North America Veterinary Antimicrobial Susceptibility Testing Market growth?
The North America Veterinary Antimicrobial Susceptibility Testing Market has witnessed significant growth, driven by rising concerns over antimicrobial resistance and increased pet healthcare expenditures. In 2023, Thermo Fisher Scientific reported increased demand for AST solutions as regulatory scrutiny intensified, boosting market expansion.
Which segment accounted for the largest North America Veterinary Antimicrobial Susceptibility Testing Market share?
In terms of application, the livestock segment accounted for the largest market share. This is due to the high prevalence of infectious diseases in farm animals and routine monitoring, as companies like Neogen Corporation provide advanced testing kits for cattle, swine, and poultry health management.
Thanks & Regards,
Priya
sales@bussinessinsights.com
